Skip to main content
. 2021 Jul 19;8:697272. doi: 10.3389/fcvm.2021.697272

Table 3.

Serum levels of TMAO before and after 4-week and 8-week treatment with Taurisolo® in study participants stratified for diagnosis of diabetes or hypertension.

Baseline t-4wk t-8wk
Mean ±SD Mean ±SD Δ% (vs. t0) p (vs. t0) Mean ±SD Δ% (vs. t0) p (vs. t0)
Diabetes (n = 28) 3.71 ± 2.81 2.11 ± 1.15 −43.15 <0.001 0.73 ± 0.67 −80.31 <0.0001
Hypertension (n = 39) 3.02 ± 2.87 1.79 ± 1.42 −40.84 0.0001 0.64 ± 0.64 −78.88 <0.0001
No-diabetes/No-hypertension (n = 41) 1.32 ± 1.10 0.66 ± 0.63 −49.82 <0.0001 0.40 ± 0.32 −69.92 <0.0001

Statistical significance was calculated with Student's t-test; p < 0.05 was considered as significant.